Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.22.2.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Collaboration revenue $ 62,071 $ 287,190
Operating expenses:        
Research and development 5,648,952 3,887,261 16,320,090 11,598,835
General and administrative 2,280,345 2,352,268 6,259,494 6,541,717
Total operating expenses 7,929,297 6,239,529 22,579,584 18,140,552
Loss from operations (7,867,226) (6,239,529) (22,292,394) (18,140,552)
Foreign exchange (loss) gain (9,794) (1,513) 5,894 (16,837)
Other income 125,501 125,501
Net loss $ (7,877,020) $ (6,115,541) $ (22,286,500) $ (18,031,888)
Per share information:        
Net loss per share, basic and diluted $ (0.13) $ (0.27) $ (0.37) $ (0.93)
Weighted average shares outstanding, basic and diluted 60,626,830 22,502,202 60,404,886 19,482,287